[HTML][HTML] Multidrug-resistant tuberculosis management in resource-limited settings

…, ML Rich, R Gupta, J Bayona, K Blöndal… - Emerging infectious …, 2006 - ncbi.nlm.nih.gov
Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly
generated from referral hospitals in high-income countries. We evaluate the management of …

[PDF][PDF] Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis

K Blöndal - Bulletin of the World Health Organization, 2007 - SciELO Public Health
The development and expansion of WHO’s DOTS strategy was successful, with 83% of the
world’s population living in countries or parts of countries covered by this strategy by the end …

HLA class II sequence variants influence tuberculosis risk in populations of European ancestry

…, JC Barrett, LJ Gudmundsson, K Blondal… - Nature …, 2016 - nature.com
Mycobacterium tuberculosis infections cause 9 million new tuberculosis cases and 1.5
million deaths annually 1 . To identify variants conferring risk of tuberculosis, we tested 28.3 …

Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis

K Blöndal, K Rahu, A Altraja… - … International journal of …, 2013 - ingentaconnect.com
OBJECTIVE: To assess overall and cause-specific mortality among patients with tuberculosis
(TB) and multidrug-resistant tuberculosis (MDR-TB) in Estonia.DESIGN: A total of 2449 …

Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube

E Gurbanova, R Mehdiyev, K Blondal… - Microbial Drug …, 2017 - liebertpub.com
Background: Simultaneous use of genotypic and phenotypic diagnostic tools for detection of
rifampicin (RIF) susceptibility may yield discrepant results. Objective: To measure the …

Multidrug resistant tuberculosis in Iceland--case series and review of the literature

H Asgeirsson, K Blöndal, T Blöndal, M Gottfredsson - Laeknabladid, 2009 - europepmc.org
[Multidrug resistant tuberculosis in Iceland--case series and review of the literature]. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test

E Gurbanova, R Mehdiyev, K Blondal, R Tahirli… - 2016 - Eur Respiratory Soc
XpertMTB/RIF is a rapid molecular diagnostic tool detecting MTB and RIF-susceptibility within
two hours. However, indeterminate RIF-susceptibility results occur and cause uncertainty …

[PDF][PDF] Review of the National Tuberculosis Programme in the Republic of Moldova, 4-15 February 2013

P Colombani, S Ahmedov, K Blondal, S Ciobanu… - 2013 - apps.who.int
The Republic of Moldova is among the WHO European Region’s 18 high-priority countries
for tuberculosis (TB) control and among the world’s 27 high multidrug-resistant (MDR) TB …

High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons

E Gurbanova, R Mehdiyev, K Blondal, A Altraja - 2015 - Eur Respiratory Soc
Introduction: In 2013, 34.7% and 49.7% of new and previously treated tuberculosis (TB)
patients, respectively, were diagnosed with drug-resistant (DR) TB in Azerbaijan prisons. …

[PDF][PDF] WORLD HEALTH ORGANIZATION/UNITED NATIONS DEVELOPMENT PROGRAMME REVIEW OF TUBERCULOSIS CONTROL IN THE REPUBLIC OF …

…, G Tsogt, A Dadu, S Severoni, S Talevski, K Blondal… - 2009 - who-sandbox.squiz.cloud
The mention of specific companies or of certain manufacturers’ products does not imply that
they are endorsed or recommended by the World Health Organization in preference to …